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ABSTRACT
Objective: To identify the psychosocial assessments utilized with individuals with conductive and/or
mixed hearing loss as part of a broader effort by the Auditory Rehabilitation Outcomes Network
(AURONET) group to develop a core set of patient-centred outcome measures.
Design: A review of articles published between 2006 and 2016 was completed. Included studies had
more than three adult participants, were available in English, and reported a psychosocial outcome from
any treatment of mixed and/or conductive hearing loss.
Study sample: Sixty-six articles from seven databases.
Results: Sixty-six articles met our inclusion/exclusion criteria. Within this set, 15 unique psychosocial or
patient-reported outcome measures (PROs) were identified, with the Abbreviated Profile of Hearing Aid
Benefit (APHAB) and Glasgow Benefit Inventory (GBI) being the most frequently dispensed. Five of the fif-
teen were only administered in one study. In-house questionnaires (IHQs) were reported in 19 articles.
Conclusions: Only 66 (22%) of the 300 articles with outcomes contained a PRO. Some of the mostly fre-
quently employed PROs (e.g., APHAB) were judged to include only social items and no psychological
items. Lack of PRO standardization and the use of IHQs make psychosocial comparisons across treatments
in this population difficult for patients, clinicians and stakeholders.
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The consequences of untreated hearing loss are well-documented
in the literature. Many of these consequences are related to psy-
chosocial well-being including isolation, frustration, higher listen-
ing effort, aversiveness to sounds, and hearing in social
gatherings (Johnson et al. 2016; Li et al. 2014; Manrique-Huarte
et al. 2016; Monzani et al. 2008; Taljaard et al. 2016). However,
many of these articles focus on sensorineural hearing, including
age-related losses (i.e., presbycusis). Fewer articles address con-
ductive and/or mixed hearing losses, which occur across the life-
span. This lack of reference material is frustrating for clinicians
and patients as conductive and/or mixed hearing losses fre-
quently allow for a choice of treatment options (e.g., air conduc-
tion hearing aids, bone conducting devices, middle ear surgeries,
etc.). It is also difficult to compare and contrast treatments as
different studies are reporting different outcome measures.
This challenge is not unique to this population. The Outcome
Measures in Rheumatology (OMERACT) group was created over
20 years ago to foster consensus in outcome measurements
related to musculoskeletal and autoimmune diseases (The
OMERACT Process 2018; Tugwell et al. 2007). Inconsistent con-
clusions were resulting from the large array of measures rheuma-
tologists were using to make judgements about treatment
efficiencies (OMERACT 2018a). The OMERACT group recog-
nised that, in order to improve treatment efficiencies, recommen-
dations and decisions need to be based on uniform evidence-
based treatment outcomes that address the concerns and needs
of the relevant stakeholders (i.e., patients, clinicians, payers, etc.).
Another important development in this area was the Core
Outcome Measures in Effective Trials (COMET) initiative
launched in 2010. COMET maintains an up-to-date online core
outcome set (COS) database that covers over 30 disease catego-
ries (The COMET Initiative 2020).
Inspired by these key initiatives, the OMERACT framework
(The OMERACT Process 2018) was utilised to help establish the
Auditory Rehabilitation Outcomes Network (AURONET) group.
The AURONET group is an international network created to
develop a core set of patient-centred outcome measures for all
types of hearing loss and/or interventions (Tysome et al. 2015).
Other groups have also successfully utilised the OMERACT
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framework after identifying the need for outcome measurement
consensus in their respective areas (e.g. gastroenterology
(Cooney et al. 2007), chronic pain (Taylor et al. 2016), prostho-
dontics (Bassi et al. 2013), etc). Following the OMERACT struc-
ture, Tysome et al. (2015) detail how the AURONET group
generated and prioritised four core domains: economic, hearing,
physical and psychosocial. These domains represent the essential
areas that should be measured in every treatment study which
includes hearing loss. Working with this foundation of what core
areas to measure, this project begins the investigation of how to
measure these domains (OMERACT 2018b) with the ultimate
goal of defining a core outcome set (COS) in a future publica-
tion. A COS are the minimum measures to be collected in any
study to ensure standardisation (OMERACT 2018a).
To identify and quantify the outcome measures currently
employed in these domains, an overview of the literature was
undertaken. Here the AURONET group examined outcome
measures applied to adults with conductive and/or mixed hearing
losses following any treatment to improve their hearing. Separate
publications will examine each core area (i.e. hearing, physical,
economic, and psychosocial) (Hill-Feltham et al. 2019; Johansson
et al. 2018). This paper will explore psychosocial measure-
ment outcomes.
Psychosocial outcomes were identified as those outcomes
relating to education, perception of self, quality of life, impact on
family and ability to work (Tysome et al. 2015). They are pri-
marily determined using instruments that utilise patient-reported
outcomes measures (PROS) (e.g. questionnaires) “that come dir-
ectly from the patient (i.e. study subject) about the status of a
patient’s health condition without amendment or interpretation
of the patient’s response by a clinician or anyone else. A PRO
can be measured by self-report or by interview provided that the
interviewer records only the patient’s response”. (US Food &
Drug Administration 2017).
This paper aims to quantify all the measures utilised in the
psychosocial domain in adults with conductive and/or mixed
hearing losses following any treatment to improve their hearing.
With over 135 adult hearing-related questionnaires identified in
the literature (Akeroyd et al. 2015), this report and its counter-
parts may be of interest to clinicians and researchers wanting to
strengthen and standardise their COS.
Materials and methods
This project was supported by a grant from the William Demant
Foundation (previously Oticon Foundation).
This review was registered prospectively in the PROSPERO
International prospective register of systematic reviews
(CRD42016039703) (Tysome et al. 2016) as a systematic review
was initially intended. However, as the methodology did not
strictly adhere to the Preferred Reporting Items for Systematic
Review and Meta-Analysis Protocols (PRISMA-P) guidelines
(Moher et al. 2015), it was recategorized as an overview (Grant
& Booth 2009). An overview of surveys describes the literature
but does not necessarily evaluate its quality.
Ethical considerations
This article represents a review of previously published articles.
No identifiable patient details are included.
Information sources and search strategy
A search of articles published over a 10-year period (2006–2016)
was conducted. Seven databases were explored: Ovid MEDLINE,
Cochrane Library, Embase, CINAHL, PsycINFO, ScienceDirect
and ISI Web of Science. Grey literature (i.e. information from
less formal publication sources) was not sought or included. The
terms and syntax of the initial literature search were developed
with the assistance of health sciences librarian Laureen P.
Cantwell, MSLIS, to target Ovid MEDLINE (detailed in
Supplementary Appendix A). This strategy was then modified, as
needed, to search the remaining databases.
Study selection process
To obtain a comprehensive result, minimal filters were applied.
The initial scope were articles (1) published between 2006 and
2016 that (2) reported an outcome(s) from a treatment(s) of
mixed and/or conductive hearing loss. This initial search yielded
1434 articles.
After the removal of duplicates (58), 1376 articles remained
for review. These articles were split into smaller groups and then
manually screened by the authors grouped in pairs. Each individ-
ual in the pair reviewed their group of articles independently,
documenting their decision and reason for inclusion or exclu-
sion. Any disparities not resolved between pairs were brought to
the larger authorship group to reach an agreement to minimise
the risk of bias. This pair review excluded 886 articles, leaving
485 full-text articles to assess for psychosocial outcomes. An
exhaustive list of outcome measures was created from the 485
articles (Supplementary Figure 1). Each identified outcome meas-
ure was then assigned a domain (i.e. hearing, physical, economic,
and psychosocial) during a consensus meeting of the authors in
Nijmegen, 2017. Articles for this report were excluded if (1) they
did not report a psychosocial outcome measure, (2) their full-
text was not available in English, (3) it identified as a review art-
icle, (4) they reported less than four participants, or (5) included
strictly paediatric participants (i.e. <16 years of age). Articles
with adults and paediatric populations were included if the adult
treatment outcomes were reported separately. Studies with less
than four participants were excluded as a systematic review with
a parallel meta-analysis was initially planned and very small
studies were thought to be of a high risk of selection bias.
Data items
Sixty-six articles met our inclusion and exclusion criteria (Figure
1, Supplementary Appendix B). Data extracted from the full-text
of these articles were input into a custom database designed
using FileMaker (15 ProAdvanced, version 15.0.04.400,
FileMaker, Inc, Santa Clara, USA) by the first author. The fields
included: Title; author(s); year of publication; publication (i.e.
journal); location; number of participants; type of hearing loss
(e.g. acquired, conductive, unilateral); diagnosis (e.g. atresia);
intervention (e.g. ossiculoplasty); study type (e.g. chart review)
and outcome measure (e.g. pure-tone average). The quality of
the study was not examined.
Data analysis and synthesis
The first author was responsible for separating, analysing and
summarising the data items related to psychosocial outcome
measures and writing portions of the manuscript content
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related to this topic. The other authors catalogued and classi-
fied outcome measures, examined data, wrote and edited por-
tions of this manuscript and contributed their expertise to the
design of the review. It was decided that the data would be
presented as frequency counts with in-depth descriptions as
psychosocial measures require more subjective judgements
than the other domains.
Results
The 66 articles originated from 20 different countries
(Supplementary Table 1) primarily located in Europe, including
Germany (9), England (8), the Netherlands (7), Italy (6), and
Switzerland (6). The number of participants ranged from 4 to
894 (Mdn¼ 19) (Supplementary Table 1). Only 10 of the articles
reported ear surgery outcomes (e.g. canalplasty, stapedotomy,
tympanoplasty, etc.), while the remaining 56 reported treatment
outcomes from bone conduction or middle ear technologies. 28
of the 55 articles focussed on percutaneous bone conduction sol-
utions from Cochlear (Gothenburg, Sweden) and/or Oticon
Medical (Askim, Sweden) and twelve on a specific middle ear
implant (VibrantVR Soundbridge
TM
, Med-El, Innsbruck, Austria).
The study type or design (Supplementary Table 1), if not
reported in the paper, was inferred by the AURONET group
(denoted  in Supplementary Table 1). Thirteen of the studies
were prospective, interventional where subjects were evaluated
before and after treatment. Four of these thirteen were multi-
centre studies.
Another 13 were identified as retrospective projects. Five of
these thirteen evaluated an intervention, one using a multicentre
design. Four retrospective projects also included a cross-sectional
survey and five compared two different treatments, one using a
multicentre setting.
Twelve of the sixty-six were classified as comparative as two
different technologies or surgical techniques were being evaluated
prospectively. Two prospective evaluations completed measures
only postoperatively.
Seven were classified at chart reviews. Another six were chart
reviews with an accompanying survey and four were postal or
telephone surveys. Two studies were identified as observational
projects, one prospective and one retrospective, and six were
described as a single-subject repeated measures design with
greater than four participants.
The number of unique psychosocial or PROs catalogued
across the 66 articles was 16 (Supplementary Table 2). Forty-four
studies administered one questionnaire, fourteen articles admin-
istered two questionnaires, seven articles administered three
questionnaires and one study administered four questionnaires.
This totalled 96 occurrences. The two most popular measures
were the Abbreviated Profile of Hearing Aid Benefit (APHAB;
22 articles) and Glasgow Benefit Inventory (GBI; 20 articles). All
questionnaires are described in detail below.
Psychosocial items were broken into two categories: psycho-
logical items and social items (Supplementary Table 2). This was
done as social items may not directly address psychosocial well-
being (e.g. from the APHAB, “When I am having a quiet conver-
sation with a friend, I have difficulty understanding”.), but much
can be inferred from these questions. Whereas psychological
items (e.g. from the HHI, “Does your hearing problem cause you
to feel depressed?”) addressed this measure more directly.
Abbreviated Profile of Hearing Aid Benefit (APHAB)
The Profile for Hearing Aid Benefit was shortened by Cox and
Alexander (1995) to create the Abbreviated Profile of Hearing
Aid Benefit (APHAB). This validated questionnaire contains 24
items with 3 additional checkbox questions about previous
experience (e.g. none), usage (e.g. less than one-hour per day)
and degree of hearing difficulty without wearing hearing aids
(e.g. moderate). The 24 remaining items are separated into four
subsets: ease of communication, reverberation, background noise
and aversiveness of sound scored on a Likert scale from A to G.
The number of psychosocial items the APHAB contains was
scored to be 12 social items and zero psychological items
(Supplementary Table 2).
It was the only PRO administered in 11 of the 66 papers. In
the remaining 11 occurrences (22 articles in total), the APHAB
was mainly paired with either the GBI (5 articles) or SSQ (3
articles). Only one of the 22 articles reported a PRO after ear
surgery (i.e. stapedotomy). The most common study type was a
prospective interventional and/or comparative design
(13 articles).
Baha Aesthetic, Hygiene and Use (BAHU)
The Baha Aesthetic, Hygiene and Use (BAHU) questionnaire
was administered in one study, combined with the APHAB and
GBI. BAHU is a newly developed, unvalidated measure to evalu-
ate a transcutaneous bone conduction device (Cochlear
TM
BahaVR
Attract system, Cochlear) using Likert scales from one to five to
ask recipients to score the system’s aesthetics, hygiene, ease of
placement and stability of attraction (GaweRcki et al. 2016). The
number of psychosocial items the BAHU contains was scored to
be zero (Supplementary Table 2).
Binaural Hearing Aid Questionnaire (BHAQ)
The Binaural Hearing Aid Questionnaire (BHAQ), developed
and evaluated by Chung and Stephens (1986), consists of four
sections. Section A (13 items) asks about use and handling;
Section B (11 items) examines listening ease in different environ-
ments; Section C (8 items) probes localisation abilities; and
Section D is an open-ended response. The questionnaire aims to
measure differences between conditions (i.e. two hearing aids as
opposed to one). It was utilised in one project, along with the
SSQ, to evaluate subjects with congenital unilateral conductive
loss obtaining a percutaneous Baha. It was judged to have one
psychological item (i.e. one question asks if the respondent’s life
has become more or less normal with two aids) and eleven
social items.
Client Orientated Scale of Improvement (COSI)
The Client Orientated Scale of Improvement (COSI) is a unique
PRO where patients define up to five listening situations in
which they struggle (Dillon, James, and Ginis 1997). It is a vali-
dated measure that is widely used in clinical settings. And while
extensively popular with clinicians, it appeared in only three
studies combined with other PROs (e.g. GBI (2 articles), IHQ (2
articles)). It was found to have five social items as subjects are
asked to describe listening situations. It is probable that many of
these situations are social environments (e.g. communication
with family, co-workers, etc.).
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Entific Medical Systems Questionnaire (EMSQ)
The Entific Medical System Questionnaire (EMSQ) is a 15-item
PRO administered in three studies all investigating percutaneous
Cochlear Baha interventions. It was the sole questionnaire col-
lected from two of the studies and combined with the COSI,
GBI and HHI in the third. The questions explore use and han-
dling (3 items), sound quality (3 items) and satisfaction (2 items)
(Dutt et al. 2002). For research purposes, the questionnaire is
frequently modified as several items ask patients to comment on
the quality of clinical services and particular hearing aid features
(e.g. telecoil). The EMSQ was judged to have one psychological
item (i.e. “Which word or phrase best describes your present
feelings about your hearing aid and its use?”) with multiple
answers (e.g. reduces stress) possible. Another question asks the
subject to rate their satisfaction in seven different listening envi-
ronments (e.g. “How would you rate your hearing aid being with
family or friends at home?”); consequently, the number of social
items was documented as eight.
Glasgow Benefit Inventory (GBI)
The Glasgow Benefit Inventory (GBI) is a validated 18-item
post-intervention questionnaire scored on a five-point Likert
scale to assess outcomes for a range of otorhinolaryngological
interventions (Robinson, Gatehouse, and Browning 1996). It was
judged to have four social items (e.g. “Have you been able to
participate in more or fewer social activities?”) and eleven psy-
chological items (e.g. “Do you feel better or worse
about yourself?”).
It was utilised in 19 studies of varying designs of which only
two were ear surgeries. It was the sole PRO reported in eleven of
the articles and combined with the APHAB in five others.
Glasgow Hearing Aid Benefit Profile (GHABP) and Glasgow
Hearing Aid Difference Profile (GHADP)
The Glasgow Hearing Aid Benefit Profile (GHABP) was adminis-
tered in three articles, overlapping with the Glasgow Hearing
Aid Difference Profile (GHADP) in one article. All investigated
bone or middle ear technologies (i.e. percutaneous and transcuta-
neous bone conduction devices and middle ear implants) The
GHABP is designed for new hearing aid recipients, while the
GHADP is meant to evaluate a new technology dispensed to an
existing user. The questions, format and scoring are the same
for both.
The GHABP and GHADP ask respondents to reflect on four
speech hearing situations (e.g. “Having a conversation with one
other person when there is no background noise”.) and to
answer six questions about each situation. Each question is
scored on a five-point Likert scale to assess their use, satisfaction,
initial disability, initial handicap, aided benefit and aided handi-
cap (Gatehouse 1999; Whitmer, Howell, and Akeroyd 2014).
Their initial disability and aided benefit were scored to be social
questions (i.e. 8 items), while their initial handicap (i.e. “How
much does this situation worry, annoy or upset you?) and aided
handicap were judged to be psychological questions (i.e. 8 items).
The GHABP and GHADP also allow the patient to define add-
itional situations to assess like the COSI.
Health Utilities Index (HUI)
The Health Utilities Index (HUIVR ) is a proprietary health-status
classification system developed from research originating at
McMaster University, Hamilton, Ontario, Canada (Horsman
et al. 2003). It was administered in two studies in this review:
once with the GHABP to evaluate a middle ear implant (Vibrant
Soundbridge, Med-El) using a multicentre single-subject repeated
measures design, and once with the APHAB to evaluate the
Codacs
TM
Investigational Device (Cochlear) with stapes prosthesis
using a multicenter prospective interventional design. Both stud-
ies utilised the HUI Mark 2 (HUI2) and Mark 3 (HUI3) self-
administered 15-item questionnaire format.
The HUI2 and HUI3 are separate but complementary tools
used to describe an individual’s comprehensive health status. The
HUI2 classification system has six attributes (i.e. sensation,
mobility, emotion, cognition, self-care and pain). Each attribute
has multiple levels (e.g. emotion has five levels, Level 1 is
described as “Generally happy and free from worry”.). The HUI3
classification system has eight attributes (i.e. vision, hearing,
speech, ambulation, dexterity, emotion, cognition and pain) with
multiple levels. Here we judged HUI2 and HUI3 to each has one
social and one psychological item. However, as the scoring sys-
tem uses a complex, proprietary algorithm to calculate a health-
related quality of life (HRQL) score for both the HUI2 and
HUI3, it is difficult to establish the weight of each attribute in
the final scoring. In the other PROs, all questions are typically of
equal weight.
Hearing Device Satisfaction Scale (HDSS)
The Hearing Device Satisfaction Scale (HDSS) was developed by
Symphonix (Symphonix was acquired by Med-El) to evaluate
pre-operative hearing aid use and post-operative fitting of the
Vibrant Soundbridge (Luetje et al. 2002). It consists of 21 items
scored on a five-point Likert scale from very dissatisfied to very
satisfied. Many topics are covered (e.g. cosmetics, sound quality,
reliability, etc.,); however, only two questions were scored social
items (i.e. speech in background noise and telephone use) and
one as a psychological item (i.e. respondents are asked to rate
the improvement in their quality of life). It was administered in
four different studies, three with Vibrant Soundbridge (Med-El)
as the intervention and one with Bonebridge (Med-El). It was
the sole PRO in two articles and grouped with the APHAB and
GBI in the other two.
Hearing Handicap Inventory (HHI)
The Hearing Handicap Inventory (HHI) for Adults was created
and validated by Newman et al. (1990) by modifying the HHI
for the Elderly. It consists of 25-items on two subscales, emo-
tional and social/situational, scored using a three-point Likert
scale (i.e. yes, sometimes, no) (Newman et al. 1991). It was
judged to have 13 psychological items (e.g. “Does your hearing
problem make you irritable?”) and 12 social items (e.g. “Does
your hearing problem cause you difficulty when attending
a party?”).
It was administered in two studies (with the SSQ (1 article)
and with the COSI, EMSQ and GBI (1 article)) to collect cross-
sectional data while retrospectively investigating treatment out-
comes for percutaneous bone conducting devices.
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Hearing Implant Sound Quality Index (HISQUI)
The Hearing Implant Sound Quality Index (HISQUI) is a 29-
item questionnaire available from Med-El. It is designed to be
administered with many of their products (e.g. cochlear implant,
bone conduction implant, auditory brainstem implant, etc.).
However, literature regarding its validation could only be located
for cochlear implant users (Amann and Anderson 2014). Using a
seven-point Likert scale, respondents score their effort and audi-
tory abilities from never to always (e.g. “Can you effortlessly dis-
tinguish single instruments in a familiar piece of music?”).
It was scored to have ten social items (e.g. “When back-
ground noise is present, can you effortlessly participate in a con-
versation with friends or family members?”) and zero
psychological items. It was administered once with the GBI and
NCIQ in a retrospective investigation of a middle ear implant
(Vibrant Soundbridge, Med-El).
In-house Questionnaires (IHQs)
In-house Questionnaires (IHQs) were reported in 19 articles
(Supplementary Table 3). The number of items they included
ranged from 1 to 18 (Mdn¼ 3). The total number of psycho-
logical items across all questionnaires was five (in 5 articles). All
five questions asked about the respondent’s quality of life. Social
items were judged to be present in seven IHQs; all asked about
speech hearing abilities in different listening situations. An IHQ
was the only reported PRO in ten articles. Five of the 19 articles
reported on-ear surgeries with the remaining 14 investigating
treatment from bone-conducting or middle ear technologies (i.e.
12 percutaneous bone conducting devices, one transcutaneous
bone-conducting system and one middle ear implant). Two of
the IHQs (Huber, Schrepfer, and Eiber 2012; Karkas et al. 2009)
were designed to collect feedback from surgeons and did not
include any PRO items.
International Outcome Inventory for Hearing Aids (IOI-HA)
The International Outcome Inventory for Hearing Aids (IOI-
HA) is a 7-item questionnaire developed and validated to self-
assess hearing aid fitting outcomes (Cox & Alexander 2002; Cox
et al. 2000). Each question, measured on a five-point Likert scale,
aims to measure a different outcome: use, benefit, residual activ-
ity limitations, satisfaction, residual participation activities,
impact on others and quality of life (Cox and Alexander 2002).
Three of these questions (i.e. benefit, residual activity limitations
and residual participation activities) were scored as social items
and two (i.e. impact on others and quality of life) were scored as
psychological items.
It was administered in four studies, three times as the sole
PRO and once with an IHQ. All four studies investigated
implantable technologies (i.e. percutaneous bone conducting
device (2 articles); middle ear implant (2 articles)); however, no
two study designs were alike.
Nijmegen Cochlear Implant Questionnaire (NCIQ)
The Nijmegen Cochlear Implant Questionnaire (NCIQ) is a
lengthy 60-item PRO with three domains: physical (30 items),
psychological (10 items) and social (20 items). It is marked on a
five-point Likert scale from never to always. It was administered
once with the GBI and HISQUI in a retrospective investigation
of a middle ear implant (Vibrant Soundbridge, Med-El).
It was scored to have twenty social items (e.g. “Does your
hearing impairment present a serious problem when you are
with friends?”) and ten psychological items (e.g. “Does your
hearing impairment undermine your self-confidence?”).
However, it is designed for, and has only been validated with,
cochlear implant users (Hinderink, Krabbe, and Van Den Broek
2000). Some of the questions are less applicable to individuals
with mixed and/or conductive hearing losses (e.g. “Are you able
to shout if you need to?”).
Speech, Spatial and Qualities of Hearing Scale (SSQ)
The Speech, Spatial and Qualities of Hearing Scale (SSQ) is a
validated 49-item PRO scored using a visual analog scale (VAS)
from zero to ten (Gatehouse & Noble 2004). It contains three
subscales: speech hearing (14 items), spatial hearing (17 items)
and qualities of hearing (18 items). It was judged to have 20
social items (e.g. “Do you have to put in a lot of effort to hear
what is being said in conversation with others?”) and zero psy-
chological items.
The SSQ was administered in ten studies: in five articles it
was the sole PRO, in two studies it was combined with the
APHAB and an IHQ, and in the remaining three it was com-
bined with either the APHAB, BHAQ or HHI. Only one of the
studies reported on an ear surgery (i.e. canalplasty), while the
remaining investigated bone conduction or middle ear technolo-
gies (e.g. percutaneous bone conducting devices (6 articles)). The
most common study type was a chart review (3 articles), with
two of the three administering the SSQ to obtain cross-sec-
tional data.
Tinnitus Handicap Inventory (THI)
The Tinnitus Handicap Inventory (THI) is a 25-item PRO cre-
ated and validated by Newman, Jacobson, and Spitzer (1996).
Questions are separated into three subscales: functional (12
items), emotional (8 items) and catastrophic (5 items), and
scored using a three-point Likert scale. It was judged to have 13
psychological items (e.g. “Because of your tinnitus, do you feel
frustrated?”) and 12 social items (e.g. “Does the loudness of your
tinnitus make it difficult for you to hear people?”).
It was the sole PRO administered in one study (Freni et al.
2014) retrospectively comparing stapedotomy techniques.
Discussion
The value of patient-reported outcome measures in the evalu-
ation process of hearing loss interventions has been promoted
since the mid-1980s (Hampson 2012). PROs are an important
component of health-related study designs as they document
unobservable symptoms, concepts and experiences only known
by the respondent. Audiometric measures, determined to be in
the hearing domain by the AURONET group, alone are insuffi-
cient to assess the hearing-related quality of life. This paper con-
sidered all administered questionnaires to separate, evaluate and
document any psychosocial measures. Most of the research origi-
nated from European centres; however, as we only included
articles with English full-text, this observation has lim-
ited generality.
Only 66 (22%) of the 300 articles (Supplementary Figure 1)
that met our inclusion/exclusion criteria contained at least one
PRO, demonstrating underuse of PROs in adults treated for
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conductive and/or mixed hearing losses. It is promising that only
15 unique PROs (removing IHQs) were catalogued across the 66
articles. This small number should indicate that the same PROS
are being administered across studies, which should allow for
meaningful comparisons. However, five of the questionnaires
(i.e. BAHU, BHAQ, HISQUI, NCIQ, THI) were only reported in
one article, making comparisons impossible. In addition, the
HISQUI and NCIQ have only been validated, to our knowledge,
with cochlear implant (CI) users.
All PROs, except for the BAHU (Supplementary Table 2),
evaluated psychosocial well-being through the inclusion of social
items (i.e. asking how the respondent understands speech in dif-
ferent listening environments). And although these responses
relate to psychosocial health, they also contribute valuable infor-
mation to the hearing domain. These complex interactions
between domains are unavoidable. However, the AURONET
group aims to be mindful of these relationships when developing
a core set of patient-centred outcome measures to create a com-
prehensive balanced assessment battery that minimises
redundancies.
No psychological items were deemed to be present in five of
the PROs (Supplementary Table 2): APHAB, BAHU, COSI,
HISQUI and SSQ. This observation is important as the APHAB
and SSQ were two of the most frequently administered ques-
tions, with 22 and 10 occurrences respectively. Consequently,
dispensing these questionnaires as the sole PRO may limit the
ability of the examiner to accurately evaluate the respondent’s
psychosocial health.
It should be noted that BAHU, EMSQ, HDSS and HISQUI
are manufacturer-developed (i.e. Cochlear and Med-El) PROs
tailored to evaluate their respective products. The number of
questions ranged from 4 to 29 with all but the BAHU asking
respondents to evaluate their hearing abilities in different social
situations (Supplementary Table 2). And although valuable infor-
mation can be extracted to assess benefit, their narrow purpose
makes comparisons across treatments challenging. In addition,
researchers and clinicians are unlikely to utilise these assessments
outside of their intended scope, even with modifications, as
more suitable options are available. However, it should be men-
tioned that the EMSQ contained one unique psychological item
that asked subjects to describe their feelings about their device
and its use, with closed set and open response options.
Ten PROs remain after eliminating the manufacturer-devel-
oped and CI user validated assessments: APHAB, BHAQ, COSI,
GBI, GHABP/GHADP, HUI, HHI, IOI-HA, SSQ and THI. All
except the HUI would be considered by most to be disease-spe-
cific questionnaires. They are designed to assess or detect
changes in a specific population (i.e. hearing loss). The HUI, a
valuable generic measure administered in two studies that con-
tain two social and two psychological items, is only available to
those who purchase the patented software. This could be a limi-
tation for some investigators.
Only ten (15%) of the 66 articles reported outcomes related
to ear surgery (e.g. stapedotomy). Each of these studies only
administered one PRO: APHAB (1), GBI (2), IHQ (5), SSQ (1),
THI (1). As previously stated, the APHAB and the SSQ do not
contain any psychological items. Two of the five IHQs (Huber,
Schrepfer, and Eiber 2012; Karkas et al. 2009) were dispensed to
surgeons. The remaining three each included only two questions
that assessed either tinnitus severity, surgical satisfaction, global
satisfaction, phone usage or hearing impairment.
The creation of new PROs, whether by the manufacturer or
the investigator using study-specific IHQs, most likely originates
from a lack of awareness and/or need. Existing validated ques-
tionnaires may not evaluate a specific feature (e.g. magnet
strength in a transcutaneous bone conduction system) of interest
to the examiner. However, this should be avoided whenever pos-
sible (Velentgas, Dreyer, and Wu 2013). Unique PROs limit the
abilities of stakeholders to make comparisons across treatments
and populations. Without a lengthy testing period, a new PRO
may also fail to measure what was intended. A study that admin-
isters a unique PRO should also administer a questionnaire with
established reliability and validity (Velentgas, Dreyer, and
Wu 2013).
Of the 19 IHQs catalogued in this review (Supplementary
Table 3), 8 contained no psychosocial items. The remaining con-
tained no more than one psychological question and 0–7
(Mdn¼ 0) social items. One of the most common IHQ items
was about device usage, the specific amount of time worn.
Investigators are likely inferring a strong positive correlation
with benefit from this item.
This desire by investigators to document device usage time
using PROs is one of many issues to be addressed by the
AURONET group in the next step. Each of the items and/or
measures identified in this review will now undergo an assess-
ment using the OMERACT three-part filter of truth, discrimin-
ation and feasibility (The OMERACT Process 2018). It is critical
that each measure is stable, sensitive, practical to administer and
valid (i.e. measures what it claims to measure).
Conclusion
The information contained in this overview is an important first
step to successfully finalise a core outcome set for this popula-
tion. Researchers and clinicians may be stationary in their meth-
ods and opposed to change. However, this review clearly
establishes a lack of standardisation in the psychosocial domain
and the need for consistent, and possibly new or different, meth-
ods. This is important to communicate to stakeholders (i.e.
patients, clinicians, investigators, manufacturers, etc.) so that cur-
rent and future treatment alternatives can be uniformly and
objectively evaluated.
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